Publications
5674 Results
- Journal / Conference
- Blood 120(21):abst. 129; American Society of Hematology Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918
Declining rates of treatment-related mortality recent in patients with newly-diagnosed AML given "intense" induction regimens: a report from SWOG and MD Anderson
- Journal / Conference
- Blood 120(21):abst.2489; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0112, S0301, SWOG-9031, SWOG-9333
Single-cell network profiling (SCNP)-based classifier to predict response to induction therapy in elderlly patients with acute myeloid leukemia (AML): validation in two independent sample sets from ECOG and SWOG trials
- Journal / Conference
- Blood 120(21)abst. 540; American Society of Hematology Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9333, SWOG-9500, S9617
Prognostic significance of the French-American-British (FAB) morphologic subclassification of "acute myeloid leukemia, not otherwise specified" in the 2008 WHO classification: analysis of 5,848 newly diagnosed patients from HOVON, MRC, SWOG, and MD Anderson Cancer Center
- Journal / Conference
- Blood 120(21):abst.543; American Society of Hematology Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9704
MYC protein expression, but not high grade morphology, is associated with poor outcome in non-Burkitt diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study
- Journal / Conference
- Blood 120(21):abst. 3535; American Society of Hematology Annual Meeting, poster;
- Year
- 2012
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Differences in outcomes in males and females with diffuse large B-cell lymphoma and follicular lymphoma treated with rituximab (ECOG E4494, CALGB 9793, SWOG E4494, E1496)
- Journal / Conference
- Cancer Epidemiology Biomarkers and Prevention 21(10):1823-1832
- Year
- 2012
- Research Committee(s)
- Cancer Control
- PMID
- PMID22879203
- PMC
- PMC3467348
- Study Number(s)
- SWOG-9217
Associations of serum sex steroid hormones and 5a-androstane-3a,17B-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride
- Journal / Conference
- American Journal of Epidemiology 175(2):
- Year
- 2012
- Research Committee(s)
- Cancer Control
- PMID
- PMID22759721
- PMC
- PMC3493197
- Study Number(s)
- SWOG-9217
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial [PMID22759721; PMC3493197]
- Journal / Conference
- International Journal of Radiation Oncology, Biology & Physics 84(3):e291-297
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID22682806
- PMC
- n/a
- Study Number(s)
- R9704
Five year results of US Intergroup/RTOG 9704 with postoperative CA 19-9 < 90 U/mL and comparison to the CONKO-001 Trial
- Journal / Conference
- Current Oncology Reports 14(6):502-508;
- Year
- 2012
- Research Committee(s)
- Outcomes and Comparative Effectiveness
- PMID
- PMID22907283
- PMC
- PMC3490046
The automatic clinical trial: leverging the electronic medical record in multisite cancer clinical trials
- Journal / Conference
- Clinical Cancer Research 18(14):3731-3736
- Year
- 2012
- Research Committee(s)
- Myeloma
- PMID
- PMID22675175
- PMC
- PMC3744099